LOADING
Comparing Microsoft Corporation (MSFT) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $2.78T | $142.9B |
| P/E Ratio | 22.3 | 19.1 |
| Forward P/E | 19.3 | 8.5 |
| PEG Ratio | 1.15 | 3.77 |
| EPS | $16.79 | $1.31 |
| Revenue Growth (YoY) | 18.3% | 5.4% |
| Profit Margin | 39.3% | 11.8% |
| Return on Equity | 34.0% | 8.3% |
| Dividend Yield | 0.97% | 6.82% |
| Beta | 1.10 | 0.29 |
| 52-Week High | $551.05 | $28.28 |
| 52-Week Low | $355.51 | $21.97 |
| Volume | -- | -- |
Microsoft Corporation is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.